
National Research Corporation NRC
€ 17.83
4.52%
Quartalsbericht 2025-Q3
hinzugefügt 07.11.2025
National Research Corporation ROA 2011-2026 | NRC
ROA Jährlich National Research Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.3 | 24.38 | 23.78 | 27.93 | 29.28 | 27.81 | 18.02 | 17.01 | 13.64 | 14.02 | 13.95 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 29.28 | 13.64 | 21.37 |
ROA Vierteljährlich National Research Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.56 | 12.84 | 18.1 | 9.5 | 16.06 | 18.3 | 18.55 | 17.18 | 23.33 | 22.92 | 23.06 | 17.3 | 23.48 | 17.94 | 23.83 | 18.36 | 25.54 | 26.53 | 26.43 | 21.77 | 29.11 | 29.26 | 30.16 | 21.42 | 27.89 | 27.03 | 27.71 | 20.59 | 23.85 | 20.64 | 17.8 | 12.9 | 16.82 | 17.48 | 16.74 | 12.26 | 15.5 | 14.81 | 14.2 | 9.12 | 12.64 | 12.92 | 12.88 | 10.85 | 14.29 | 14.2 | 14.17 | 10.55 | 14.13 | 14.27 | 15.12 | 11.36 | 13.99 | 13.04 | 11.42 | 8.38 | 2.63 | 2.31 | 3.43 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 30.16 | 2.31 | 17.13 |
ROA anderer Aktien in der Diagnostik & Forschung
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
-67.95 | $ 2.96 | -2.8 % | $ 96.1 K | ||
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | ||
|
Castle Biosciences
CSTL
|
3.43 | $ 40.46 | 2.7 % | $ 1.12 B | ||
|
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 35.0 | 2.76 % | $ 374 M | ||
|
Brainsway Ltd.
BWAY
|
-8.53 | $ 24.11 | 3.1 % | $ 99.4 M | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
-14.58 | $ 102.49 | 0.15 % | $ 19 B | ||
|
BioNano Genomics
BNGO
|
-146.1 | $ 1.26 | -3.14 % | $ 1.6 M | ||
|
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-29.37 | $ 115.34 | 1.14 % | $ 14.2 B | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
-37.07 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
5.03 | $ 218.15 | -0.34 % | $ 159 B | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
15.78 | $ 67.61 | 1.04 % | $ 4.68 B | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | ||
|
Medpace Holdings
MEDP
|
19.25 | $ 584.92 | 0.42 % | $ 18.1 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
8.64 | $ 73.25 | 0.29 % | $ 28.3 B | ||
|
NeoGenomics
NEO
|
-4.81 | $ 12.26 | 1.66 % | $ 1.55 B | ||
|
CareDx, Inc
CDNA
|
-40.76 | $ 21.05 | 2.41 % | $ 1.13 B | ||
|
Celcuity
CELC
|
-45.6 | $ 111.78 | 2.16 % | $ 4.41 B | ||
|
DarioHealth Corp.
DRIO
|
-61.65 | $ 10.2 | 1.8 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-3.5 | $ 26.41 | 0.8 % | $ 799 M | ||
|
Koninklijke Philips N.V.
PHG
|
10.73 | $ 28.7 | - | $ 20 B | ||
|
Personalis
PSNL
|
-30.08 | $ 9.47 | 1.07 % | $ 561 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
IDEXX Laboratories
IDXX
|
26.96 | $ 643.53 | -4.02 % | $ 53.1 B | ||
|
Illumina
ILMN
|
-19.4 | $ 141.7 | -2.15 % | $ 22.5 B | ||
|
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
5.1 | $ 229.93 | -0.1 % | $ 41.7 B | ||
|
Charles River Laboratories International
CRL
|
0.29 | $ 210.33 | -0.07 % | $ 10.8 B | ||
|
Thermo Fisher Scientific
TMO
|
6.51 | $ 579.47 | 0.25 % | $ 221 B | ||
|
Trinity Biotech plc
TRIB
|
0.78 | $ 0.82 | 0.51 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
-12.1 | $ 46.54 | 13.32 % | $ 2.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 183.98 | -1.63 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
-44.15 | $ 9.37 | -7.87 % | $ 1.22 B | ||
|
Precipio
PRPO
|
-32.34 | $ 24.54 | 0.04 % | $ 31.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 268.23 | -1.21 % | $ 22.5 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 178.87 | -0.77 % | $ 14.8 B |